Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 119 Pages
Report ld: 3499132
Request Sample
Customized Report
Human iPS Cell Characterization Kit Market Size(US$)

CAGR 2025-2031
7.8%
Market Size,2031
USD 1,801
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Human iPS Cell Characterization Kit was estimated to be worth US$ 1072 million in 2024 and is forecast to a readjusted size of US$ 1801 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
The Human iPS Cell Characterization Kit (Induced pluripotent stem cell) contains a range of sensitive tools for the phenotypic assessment of the pluripotent status of human Embryonic stem & induced pluripotent Stem cells.
Life science reagents are the fundamental materials for life science research and development, and are widely used as consumable tools in life science research activities. According to Frost&Sullivan"s data, the global market size of biological reagents has reached US $12.8 billion in 2015 and US $17.5 billion in 2019, with a Compound annual growth rate of 8.1%.
This report aims to provide a comprehensive presentation of the global market for Human iPS Cell Characterization Kit, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Human iPS Cell Characterization Kit by region & country, by Type, and by Application.
The Human iPS Cell Characterization Kit market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human iPS Cell Characterization Kit.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Human iPS Cell Characterization Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Human iPS Cell Characterization Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Human iPS Cell Characterization Kit in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Human iPS Cell Characterization Kit Product Introduction
1.2 Global Human iPS Cell Characterization Kit Market Size Forecast
1.2.1 Global Human iPS Cell Characterization Kit Sales Value (2020-2031)
1.2.2 Global Human iPS Cell Characterization Kit Sales Volume (2020-2031)
1.2.3 Global Human iPS Cell Characterization Kit Sales Price (2020-2031)
1.3 Human iPS Cell Characterization Kit Market Trends & Drivers
1.3.1 Human iPS Cell Characterization Kit Industry Trends
1.3.2 Human iPS Cell Characterization Kit Market Drivers & Opportunity
1.3.3 Human iPS Cell Characterization Kit Market Challenges
1.3.4 Human iPS Cell Characterization Kit Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human iPS Cell Characterization Kit Players Revenue Ranking (2024)
2.2 Global Human iPS Cell Characterization Kit Revenue by Company (2020-2025)
2.3 Global Human iPS Cell Characterization Kit Players Sales Volume Ranking (2024)
2.4 Global Human iPS Cell Characterization Kit Sales Volume by Company Players (2020-2025)
2.5 Global Human iPS Cell Characterization Kit Average Price by Company (2020-2025)
2.6 Key Manufacturers Human iPS Cell Characterization Kit Manufacturing Base and Headquarters
2.7 Key Manufacturers Human iPS Cell Characterization Kit Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Human iPS Cell Characterization Kit
2.9 Human iPS Cell Characterization Kit Market Competitive Analysis
2.9.1 Human iPS Cell Characterization Kit Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Human iPS Cell Characterization Kit Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human iPS Cell Characterization Kit as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Alkaline Phosphatase Staining Assay
3.1.2 Pluripotency Markers (Protein)
3.1.3 Pluripotency Markers (mRNA)
3.2 Global Human iPS Cell Characterization Kit Sales Value by Type
3.2.1 Global Human iPS Cell Characterization Kit Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Human iPS Cell Characterization Kit Sales Value, by Type (2020-2031)
3.2.3 Global Human iPS Cell Characterization Kit Sales Value, by Type (%) (2020-2031)
3.3 Global Human iPS Cell Characterization Kit Sales Volume by Type
3.3.1 Global Human iPS Cell Characterization Kit Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Human iPS Cell Characterization Kit Sales Volume, by Type (2020-2031)
3.3.3 Global Human iPS Cell Characterization Kit Sales Volume, by Type (%) (2020-2031)
3.4 Global Human iPS Cell Characterization Kit Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cancer Research Center
4.1.2 Pathology Laboratory
4.1.3 Academic and Research
4.1.4 Contract Research Organizations
4.1.5 Others
4.2 Global Human iPS Cell Characterization Kit Sales Value by Application
4.2.1 Global Human iPS Cell Characterization Kit Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Human iPS Cell Characterization Kit Sales Value, by Application (2020-2031)
4.2.3 Global Human iPS Cell Characterization Kit Sales Value, by Application (%) (2020-2031)
4.3 Global Human iPS Cell Characterization Kit Sales Volume by Application
4.3.1 Global Human iPS Cell Characterization Kit Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Human iPS Cell Characterization Kit Sales Volume, by Application (2020-2031)
4.3.3 Global Human iPS Cell Characterization Kit Sales Volume, by Application (%) (2020-2031)
4.4 Global Human iPS Cell Characterization Kit Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Human iPS Cell Characterization Kit Sales Value by Region
5.1.1 Global Human iPS Cell Characterization Kit Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Human iPS Cell Characterization Kit Sales Value by Region (2020-2025)
5.1.3 Global Human iPS Cell Characterization Kit Sales Value by Region (2026-2031)
5.1.4 Global Human iPS Cell Characterization Kit Sales Value by Region (%), (2020-2031)
5.2 Global Human iPS Cell Characterization Kit Sales Volume by Region
5.2.1 Global Human iPS Cell Characterization Kit Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Human iPS Cell Characterization Kit Sales Volume by Region (2020-2025)
5.2.3 Global Human iPS Cell Characterization Kit Sales Volume by Region (2026-2031)
5.2.4 Global Human iPS Cell Characterization Kit Sales Volume by Region (%), (2020-2031)
5.3 Global Human iPS Cell Characterization Kit Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Human iPS Cell Characterization Kit Sales Value, 2020-2031
5.4.2 North America Human iPS Cell Characterization Kit Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Human iPS Cell Characterization Kit Sales Value, 2020-2031
5.5.2 Europe Human iPS Cell Characterization Kit Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Human iPS Cell Characterization Kit Sales Value, 2020-2031
5.6.2 Asia Pacific Human iPS Cell Characterization Kit Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Human iPS Cell Characterization Kit Sales Value, 2020-2031
5.7.2 South America Human iPS Cell Characterization Kit Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Human iPS Cell Characterization Kit Sales Value, 2020-2031
5.8.2 Middle East & Africa Human iPS Cell Characterization Kit Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human iPS Cell Characterization Kit Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Human iPS Cell Characterization Kit Sales Value
6.2.1 Key Countries/Regions Human iPS Cell Characterization Kit Sales Value, 2020-2031
6.2.2 Key Countries/Regions Human iPS Cell Characterization Kit Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Human iPS Cell Characterization Kit Sales Value, 2020-2031
6.3.2 United States Human iPS Cell Characterization Kit Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Human iPS Cell Characterization Kit Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Human iPS Cell Characterization Kit Sales Value, 2020-2031
6.4.2 Europe Human iPS Cell Characterization Kit Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Human iPS Cell Characterization Kit Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Human iPS Cell Characterization Kit Sales Value, 2020-2031
6.5.2 China Human iPS Cell Characterization Kit Sales Value by Type (%), 2024 VS 2031
6.5.3 China Human iPS Cell Characterization Kit Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Human iPS Cell Characterization Kit Sales Value, 2020-2031
6.6.2 Japan Human iPS Cell Characterization Kit Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Human iPS Cell Characterization Kit Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Human iPS Cell Characterization Kit Sales Value, 2020-2031
6.7.2 South Korea Human iPS Cell Characterization Kit Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Human iPS Cell Characterization Kit Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Human iPS Cell Characterization Kit Sales Value, 2020-2031
6.8.2 Southeast Asia Human iPS Cell Characterization Kit Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Human iPS Cell Characterization Kit Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Human iPS Cell Characterization Kit Sales Value, 2020-2031
6.9.2 India Human iPS Cell Characterization Kit Sales Value by Type (%), 2024 VS 2031
6.9.3 India Human iPS Cell Characterization Kit Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Merck KGaA
7.1.1 Merck KGaA Company Information
7.1.2 Merck KGaA Introduction and Business Overview
7.1.3 Merck KGaA Human iPS Cell Characterization Kit Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Merck KGaA Human iPS Cell Characterization Kit Product Offerings
7.1.5 Merck KGaA Recent Development
7.2 Takara Bio
7.2.1 Takara Bio Company Information
7.2.2 Takara Bio Introduction and Business Overview
7.2.3 Takara Bio Human iPS Cell Characterization Kit Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Takara Bio Human iPS Cell Characterization Kit Product Offerings
7.2.5 Takara Bio Recent Development
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Company Information
7.3.2 Thermo Fisher Scientific Introduction and Business Overview
7.3.3 Thermo Fisher Scientific Human iPS Cell Characterization Kit Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Thermo Fisher Scientific Human iPS Cell Characterization Kit Product Offerings
7.3.5 Thermo Fisher Scientific Recent Development
7.4 BD Biosciences
7.4.1 BD Biosciences Company Information
7.4.2 BD Biosciences Introduction and Business Overview
7.4.3 BD Biosciences Human iPS Cell Characterization Kit Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 BD Biosciences Human iPS Cell Characterization Kit Product Offerings
7.4.5 BD Biosciences Recent Development
7.5 Applied StemCell
7.5.1 Applied StemCell Company Information
7.5.2 Applied StemCell Introduction and Business Overview
7.5.3 Applied StemCell Human iPS Cell Characterization Kit Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Applied StemCell Human iPS Cell Characterization Kit Product Offerings
7.5.5 Applied StemCell Recent Development
7.6 Amsbio
7.6.1 Amsbio Company Information
7.6.2 Amsbio Introduction and Business Overview
7.6.3 Amsbio Human iPS Cell Characterization Kit Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Amsbio Human iPS Cell Characterization Kit Product Offerings
7.6.5 Amsbio Recent Development
7.7 Bio-Techne
7.7.1 Bio-Techne Company Information
7.7.2 Bio-Techne Introduction and Business Overview
7.7.3 Bio-Techne Human iPS Cell Characterization Kit Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Bio-Techne Human iPS Cell Characterization Kit Product Offerings
7.7.5 Bio-Techne Recent Development
7.8 ALSTEM
7.8.1 ALSTEM Company Information
7.8.2 ALSTEM Introduction and Business Overview
7.8.3 ALSTEM Human iPS Cell Characterization Kit Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 ALSTEM Human iPS Cell Characterization Kit Product Offerings
7.8.5 ALSTEM Recent Development
7.9 STEMCELL Technologies
7.9.1 STEMCELL Technologies Company Information
7.9.2 STEMCELL Technologies Introduction and Business Overview
7.9.3 STEMCELL Technologies Human iPS Cell Characterization Kit Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 STEMCELL Technologies Human iPS Cell Characterization Kit Product Offerings
7.9.5 STEMCELL Technologies Recent Development
7.10 System Biosciences
7.10.1 System Biosciences Company Information
7.10.2 System Biosciences Introduction and Business Overview
7.10.3 System Biosciences Human iPS Cell Characterization Kit Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 System Biosciences Human iPS Cell Characterization Kit Product Offerings
7.10.5 System Biosciences Recent Development
7.11 Applied Biological Materials
7.11.1 Applied Biological Materials Company Information
7.11.2 Applied Biological Materials Introduction and Business Overview
7.11.3 Applied Biological Materials Human iPS Cell Characterization Kit Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Applied Biological Materials Human iPS Cell Characterization Kit Product Offerings
7.11.5 Applied Biological Materials Recent Development
7.12 Creative Bioarray
7.12.1 Creative Bioarray Company Information
7.12.2 Creative Bioarray Introduction and Business Overview
7.12.3 Creative Bioarray Human iPS Cell Characterization Kit Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Creative Bioarray Human iPS Cell Characterization Kit Product Offerings
7.12.5 Creative Bioarray Recent Development
7.13 Elixirgen Scientific
7.13.1 Elixirgen Scientific Company Information
7.13.2 Elixirgen Scientific Introduction and Business Overview
7.13.3 Elixirgen Scientific Human iPS Cell Characterization Kit Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Elixirgen Scientific Human iPS Cell Characterization Kit Product Offerings
7.13.5 Elixirgen Scientific Recent Development
7.14 Miltenyi Biotec
7.14.1 Miltenyi Biotec Company Information
7.14.2 Miltenyi Biotec Introduction and Business Overview
7.14.3 Miltenyi Biotec Human iPS Cell Characterization Kit Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Miltenyi Biotec Human iPS Cell Characterization Kit Product Offerings
7.14.5 Miltenyi Biotec Recent Development
8 Industry Chain Analysis
8.1 Human iPS Cell Characterization Kit Industrial Chain
8.2 Human iPS Cell Characterization Kit Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Human iPS Cell Characterization Kit Sales Model
8.5.2 Sales Channel
8.5.3 Human iPS Cell Characterization Kit Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Human iPS Cell Characterization Kit was estimated to be worth US$ 1148 million in 2025 and is projected to reach US$ 1927 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 138
USD 3950.00
(Single User License)
The global Human iPS Cell Characterization Kit market was valued at US$ 1148 million in 2025 and is anticipated to reach US$ 1927 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 120
USD 2900.00
(Single User License)
The global Human iPS Cell Characterization Kit market size was US$ 1072 million in 2024 and is forecast to a readjusted size of US$ 1801 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 94
USD 4250.00
(Single User License)
The global Human iPS Cell Characterization Kit market is projected to grow from US$ 1072 million in 2024 to US$ 1801 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 157
USD 4900.00
(Single User License)
The global market for Human iPS Cell Characterization Kit was valued at US$ 1072 million in the year 2024 and is projected to reach a revised size of US$ 1801 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published Date: 2025-01-13
Pages: 93
USD 2900.00
(Single User License)
The Human iPS Cell Characterization Kit (Induced pluripotent stem cell) contains a range of sensitive tools for the phenotypic assessment of the pluripotent status of human Embryonic stem & induced pluripotent Stem cells.
Published Date: 2024-04-10
Pages: 112
USD 4900.00
(Single User License)
The Human iPS Cell Characterization Kit (Induced pluripotent stem cell) contains a range of sensitive tools for the phenotypic assessment of the pluripotent status of human Embryonic stem & induced pluripotent Stem cells.
Published Date: 2024-01-17
Pages: 94
USD 2900.00
(Single User License)
The global market for Human iPS Cell Characterization Kit was estimated to be worth US$ 1148 million in 2025 and is projected to reach US$ 1927 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-06-16
Pages: 138
The global Human iPS Cell Characterization Kit market was valued at US$ 1148 million in 2025 and is anticipated to reach US$ 1927 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-04-17
Pages: 120
The global Human iPS Cell Characterization Kit market size was US$ 1072 million in 2024 and is forecast to a readjusted size of US$ 1801 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 94
The global Human iPS Cell Characterization Kit market is projected to grow from US$ 1072 million in 2024 to US$ 1801 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 157
The global market for Human iPS Cell Characterization Kit was valued at US$ 1072 million in the year 2024 and is projected to reach a revised size of US$ 1801 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published: 2025-01-13
Pages: 93
The Human iPS Cell Characterization Kit (Induced pluripotent stem cell) contains a range of sensitive tools for the phenotypic assessment of the pluripotent status of human Embryonic stem & induced pluripotent Stem cells.
Published: 2024-04-10
Pages: 112
The Human iPS Cell Characterization Kit (Induced pluripotent stem cell) contains a range of sensitive tools for the phenotypic assessment of the pluripotent status of human Embryonic stem & induced pluripotent Stem cells.
Published: 2024-01-17
Pages: 94
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now